Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600326 · ClinicalTrials.gov registry record · Phase 2
A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection
A Phase 2 study of Tendinosis and Tendinitis, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01600326 is a Phase 2 study of Tendinosis and Tendinitis that has completed, run by University of Michigan. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01600326, a Phase 2 study of Tendinosis and Tendinitis, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of various treatment soft tendinosis also known as tendinitis.
Conditions Studied
Interventions
- PROCEDURE Tenotomy (no injection)
- DRUG Ultrasound guided platelet rich plasma injection
Study Locations (1)
Michigan
- University of Michigan Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01600326
The ClinicalTrials.gov registry entry for NCT01600326 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tendinosis appearing as the primary indexed condition, and to 2 interventions - of which Tenotomy (no injection) is the first listed.
NCT01600326 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01600326 about?
NCT01600326 is a clinical study titled "A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection". The purpose of this study is to determine the effectiveness of various treatment soft tendinosis also known as tendinitis.
What is the current status of trial NCT01600326?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2010-07. Estimated completion is 2015-07.
What conditions does trial NCT01600326 study?
This clinical trial studies the following conditions: Tendinosis, Tendinitis.
What interventions are being tested in trial NCT01600326?
The interventions under investigation include: Tenotomy (no injection) (PROCEDURE), Ultrasound guided platelet rich plasma injection (DRUG).
Who is sponsoring clinical trial NCT01600326?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01600326 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tendinosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.